Catalyst Wire Dossier Catalyst Wire Dossier

APO-dabigatran

dabigatran · Apobiologics (hypothetical/placeholder)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APO-dabigatran, covering 2022-03-21 to 2022-03-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers [Phase 4]

See pricing